Springbank

Muse Capital is an early stage venture fund investing in consumer tech, with a focus on large underserved markets poised for disruption. They focus on investing in products, services and solutions to meet the needs of tomorrow’s increasingly diverse society across how we care (women’s health, digital health, and childcare), how we live (wellness and sustainability), and how we play (gaming, entertainment, web3, and sports tech). Muse Capital’s expertise is sourcing and executing on business development opportunities for their entrepreneurs, leveraging the partners 20+ years of accelerating and operating businesses in both private and public sectors, with their global network of decision makers across F500's, entertainment, sports teams/owners, global investors, and world class tech entrepreneurs. Given their highly strategic value add, they are able to access oversubscribed deals and invest before or alongside some of the top funds in the valley including Andreessen Horowitz, Google Ventures, Forerunner, and Lightspeed to name just a few. Muse Capital’s current fund is a $45m platform dedicated to doubling down on their established track record across the consumer space, and a knack for spotting super-trends and talent early on. Their portfolio of 40+ investments includes Clarity Money (sold to Goldman Sachs), Mahmee (telehealth for new mothers, series A lead by Goldman Sachs), Midi (disrupting the $50B menopause space), Kinside (digitizing the $150B childcare industry), and Beekeeper’s Naturals (replacing the modern medicine cabinet with natural products). The team has also gained exclusive access for their strategic LPs to direct investments into prestigious later stage deals including Robinhood and Byju’s. As a female lead team of conscious capitalists, Muse Capital is a staunch advocate for diversity as better business, and proud to have a portfolio which is 50% minority/female.

Startups are super-tools to change the world. Let’s build stuff that matters. Social Planet Ventures invests in hyper-ambitious startups that want to address the world’s most pressing social challenges with solid and scaleable tech solutions. The reason is simple; We believe that in the future, some of the most valuable businesses will be those that deliver meaningful and positive social outcome for millions of people and for society at large – alongside their financial success. We search for companies with such a vision and can assist with setting a scaleable foundation in the initial and very fragile stage. Advancing social cohesion We want to invest in visionary founders with innovative superior tech solutions that strengthen social cohesion by addressing problems of inequality, marginalisation and exclusion; Education and re-skilling 20% or 50 million jobs in the European Workforce is expected to be automated by 2030. That will not lead to fewer jobs but to different types of jobs, which will require a massive re-skilling of our existing workforce to empower people to actively participate in our society. Preventive health and wellbeing By 2050, the share of people over 65 will be around 30%, compared to around 20% today. This will put a pressure on our welfare system. In EU today, we spend 3% of total public and private health care expenditures on preventive health. We expect to see wave of new ways to better detect and prevent people from getting sick to keep the same quality of care. Inclusive work-life With a shrinking workforce, we need to be much better at understanding and foster diversity, equity and inclusion to unlock the full potential of everyone. Closing the gender/skill gap in EU tech jobs alone has a potential of GDP increase of as much as €600 billion according to McKinsey. Sustainable living 100 million people in the EU is at risk of poverty or social exclusion. New technology can provide a foundation for more sustainable and inclusive communities that offers attractive careers, businesses, infrastructure, and living opportunities to secure a long-term resilient society. Inclusive financial services More than 30% of people in EU do not save for retirement because they can’t afford it. In average low-income households pays a Poverty Premium of up to €1,000 a year for essential products and services due to reasons that they cannot control, such as where they can afford to live. Open banking, blockchain and AI creates new opportunities and democratise access to financial services to create better societal resilience. About us Our investment team is based in Copenhagen and Stockholm. Alongside capital from pre-seed to Series A, we provide specialized support with product-market-impact fit, impact & ESG management, hiring and fundraising. We align ourselves with Article 9 SFDR and we measure the positive social impact of all our investments and base our compensation on the provided measurable impact.

Pivotal Ventures (“Pivotal”) is an investment and incubation company created by Melinda French Gates. We partner, invest, and advocate to remove barriers that hold people back, concentrating on areas where progress and opportunity have stalled for millions of Americans. The pursuit of a more equal and equitable United States - not just for some of us, but for everyone - is what drives us forward. It's the why behind every problem we tackle. We approach partnership with big ambitions and open minds, embracing what’s already working and innovating beyond traditional philanthropy. Some areas we focus on: women in technology and innovation; Women in public office; women and girls of color; adolescent mental health; paid family and medical leave; and caregiving. Inspired by our founder, we reach across communities and sectors to bring together changemakers who can scale up proven ideas and catalyze new ones. We learn from their experiences, amplify their resources, then step back so they can lead. Our impatience with the status quo is fueled by an optimism that progress is always possible.

We build and invest in companies that positively impact human health with smart solutions, breakthrough science and technology. Our focus is on innovation in digital healthcare, connected medical devices, and life sciences We focus on therapeutic and preventive technology solutions addressing unmet needs in some of the most vulnerable segments of society: women, children and the elderly. Digital transformation will continue to shape our lives and has the potential to transform care. We aim to build and support Digital Health & Life Sciences companies working to make healthcare smarter, using data to improve care and outcomes, and reinventing the patient journey. Our vision for the future of healthcare guides our investment strategy. A data driven digital transformation will shape the future of healthcare. The traditional biopharma model will evolve into an integrated model, where prevention, precision cure, and care management will coexist in a highly personalized patient-centric solution. Our goal is to support the creation of life transforming care products and therapies. We believe the future of healthcare lies in supporting the next-generation of founders and teams who will lead us there. What do we look for?Innovation and groundbreaking opportunities in our sectors of focus: digital health, life sciences, tech-enabled care delivery, and connected devices Innovative treatments for Central Nervous System (CNS) disorders, in particular neurodevelopmental disorders, mental health and epilepsy Founders and teams with domain expertise who seek collaborative investment partners Investments that span development and commercial phases, with a focus on early stage opportunities (Pre-Seed to Series A). Our investment approachOur investment approach combines direct investments in early-stage companies with venture creation from bold ideas in global innovation hubs Our goal is to enable talented entrepreneurs to scale more quickly and effectively through access to our capital, enterprise capabilities and consumer touchpoints, while offering expertise and insights from Angelini’s unique perspective. We invest primarily across Europe, North America and Israel, recognizing that healthcare technology innovation is occurring in many cities around the world. We have committed €300M for investments and company creation in digital health and life sciences. What do we commit to you?Active and involved healthcare investors who operate with integrity, approachability, and transparency A team of passionate healthcare and venture capital experts diverse in demographic and experience A track record of success and experience navigating the ups and downs of early-stage company building Access to a world-class advisory board to leverage C-level experience, expertise, and leadership in healthcare

We aim to support passionate entrepreneurs building visionary brands in positive living that will make the daily lives of consumers healthier, happier and more meaningful. We seek to partner with companies that are narrowing The Wellness Gap: the quantifiable delta that has grown dramatically over the past two decades as economic indicators such as GDP per capita have increased while measures of overall wellbeing, including physical and mental health, have stagnated or decreased. We are most focused on overlooked or stigmatized communities that have resulted in underserved markets. These are the areas where we see opportunity: Disruptive Healthcare Care Economy Consumer Wellbeing Connection & Community With a particular interest in the following demographics: Women Immigrants Caregivers Aging Adults Gen Z

At the foundation of each of our investments is a commitment to helping our portfolio companies grow so they can better serve employers of all size. Employers make significant investments to make health care more accessible and easier to navigate. Our portfolio companies bring innovations to market that meet some of employers’ most pressing health care needs, including care navigation, advanced primary care, fertility planning and advanced analytics. Here are some of our current key areas of focus: Drug Management: Prices for drugs – particularly in high-cost categories like oncology, obesity and cell gene therapy – are outpacing inflation. We seek investment opportunities that address drug spend and access, with a specific focus on high-cost drugs or conditions that are highly prevalent in employer-sponsored insurance populations. Data and Analytics: Employers need solutions that make the vast amount of available health care data actionable and tailored to their insured populations. As such, we consider investment opportunities that provide the necessary infrastructure and analytic capabilities to impact administrative efficiency or drive improvements in health care quality and price transparency. Small- and Medium-Sized Business (SMB) Solutions: Rising health care costs place a severe burden on SMBs. In fact, the smallest employers are facing the biggest hikes in premium costs. Employers with just 1-10 employees saw a 12% increase in average family plan premiums in 2022. To help navigate this challenge, we weigh investment opportunities that enable SMBs to provide more affordable, high-quality, and equitable health care to employees through new purchasing and coverage models. Behavioral Health: Fragmented solutions have proven ineffective in addressing the behavioral health needs of patients. To help drive change in this area, we’re considering investment opportunities that approach patient care holistically, with behavioral and medical spend linked to create a comprehensive and unified view of the patient. Women’s Health: Despite deep investments in this area from employers, too many gaps in health and access to care still exist. There are opportunities to solve for the discrete, largely unmet, needs of women in the workforce, including but not limited to maternity, menopause, and comprehensive women’s primary care.